Source: Annual Congress 2005 - Advancements in diffuse parenchymal lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
K. M. Antoniou, E. G. Tzortzaki, N. Tzanakis, K. Sfiridaki, E. L. Kandidaki, M. Alexandrakis, D. Moraitaki, G. Maltezakis, D. Bouros, N. Siafakas (Heraklion, Alexandroupolis, Greece). Decreased levels of CXC angiogenic chemokines (IL-8, ENA-78 and GRO-α) in BALF after interferon gamma-1b treatment in IPF patients. Eur Respir J 2005; 26: Suppl. 49, 1803

Member's Comments

No comment yet.

Related content which might interest you: Angiogenic and angiostatic CXC chemokines in BALF and serum of IPF patients Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005 Levels of interleukins IL-4, IL-6, IL-8 and TNFa in sera of patients with tuberculosis before and during treatment Source: Eur Respir J 2002; 20: Suppl. 38, 556s Year: 2002 Decreased T-bet expression and changes in levels of chemokines (IP-10, MIG, RANTES, MCP-1 and IL-8) in peripheral blood of adults with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 593s Year: 2006 TNF-a and IL-10 control macrophage expression of CXCL13, a prognostic biomarker of idiopathic pulmonary fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 Enhanced IL-6 and CCL3 activity in COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006 Role of the chemokines RANTES, monocyte chemotactic proteins-3 and -4, and eotaxins-1 and -2 in childhood asthma Source: Eur Respir J 2003; 22: 310-316 Year: 2003 IL-18 and IL-12 induce inflammatory cytokines, chemokine ligand 9 (CXCL9) and T cell infiltration in pulmonary tissue Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 CC and C chemokine expression in pulmonary sarcoidosis Source: Eur Respir J 2002; 20: 1206-1212 Year: 2002 Prognostic meaning of interleukin-8 (IL-8) and interleukin-10 (IL-10) during the development of postoperative pneumonias Source: Eur Respir J 2005; 26: Suppl. 49, 633s Year: 2005 T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis Source: Eur Respir J 2011; 38: 1136-1144 Year: 2011 Endobronchial biopsy neutrophilia, IL-8, ENA-78 and neutrophil chemokine receptor (CXCR1 and CXCR2) gene expression in severe exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 588s Year: 2003 Endobronchial biopsy neutrophilia, IL-8, ENA-78 and neutrophil chemokine receptor (CXCR1 & CXCR2) gene expression in severe exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 377s Year: 2002 Endotoxin-induced release of the Th17-associated cytokine interleukin (IL)-26 in human neutrophils Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Cytokine modulators as novel therapies for airway disease Source: Eur Respir J 2001; 18: 67S-77S Year: 2001 Interleukin-18, interleukin-12, interferon γ and interleukin-18 receptor expression is decreased in the recovery phase of pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 366s Year: 2001 Pro-inflammatory cytokine changes in patients with cancer after BAL Source: Eur Respir J 2004; 24: Suppl. 48, 82s Year: 2004 Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004 Chemokines and chemokine receptors mRNA expression in lavage of COPD patients Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Serum levels of IL-5, IL-6 and IL-8 in moderate and severe asthma clusters Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018